Glucose Metabolism Reprogramming in Bladder Cancer: Hexokinase 2 (HK2) as Prognostic Biomarker and Target for Bladder Cancer Therapy.

Cancers (Basel) · 2023 · PMC9913750 · PMID 36765947

Europe PMC DOI

hedged sentence

0.0180

closest p · 0.4× alpha

0.0180

boldest claim

The sentences

near-significantp = 0.018actually significant

The normal-like samples did not stain for GLUT1, HK2, and LDHA, with the differences being significant and near-significant with regard to the LDHA and HK2 expression in the cancer sections (44.9% positivity for LDHA, p = 0.018; 35.5% positivity for HK2, p = 0.050).

also in 2,306 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.